Calcitrin: a drug based on parathyroid hormones
Calcitrin is a medication used to treat various conditions associated with bone turnover and hormonal imbalances. It contains the active substance calcitonin, which is a hormone of the parathyroid glands.
Manufacturers and international name
Calcitrin is produced by Novartis Pharma AG in Russia. The international name of the drug is Calcitonin. It is also known under the synonyms Miacalcic and Sibacalcin.
Dosage forms and composition
Calcitrin is presented in the form of a lyophilisate for the preparation of a solution for intramuscular and subcutaneous administration. The concentration of the drug is 10 IU (units of action).
The active substance in Calcitrin is calcitonin, which plays an important role in regulating bone turnover.
Indications for use
Calcitrin is used to treat the following conditions:
-
Osteoporosis: a chronic disease characterized by decreased bone density and an increased risk of fractures.
-
Bone pain associated with osteolysis and/or osteopenia: These conditions are also associated with bone loss and may cause pain.
-
Paget's disease (osteitis deformans): This is a chronic disease in which normal bone turnover is disrupted, leading to bone deformation and pain symptoms.
-
Hypercalcemia and hypercalcemic crisis: These conditions are characterized by elevated levels of calcium in the blood and require medical intervention.
-
Neurodystrophic diseases: Calcitrin can be used to treat some neurological diseases such as pain and muscle dystrophy.
-
Acute pancreatitis: inflammation of the pancreas, which may be accompanied by abdominal pain.
Contraindications and side effects
Calcitrin is contraindicated in case of hypersensitivity to the drug, as well as during pregnancy and breastfeeding.
When using Calcitrin, side effects may occur, such as nausea, vomiting, dizziness, flushing, a feeling of heat, chills, polyuria (frequent urination) and allergic reactions, including anaphylactic shock, such as tachycardia, arrhythmic heart disorders, redness of the skin, itching and swelling.
It is important to consult with your doctor before starting to use Calcitrin to evaluate the benefits of treatment and possible risks.
Dosage and method of administration
The dosage of Calcitrin and the method of application may vary depending on the individual characteristics of the patient and the nature of the disease. Usually the drug is administered intramuscularly or subcutaneously.
It is important to strictly follow your doctor’s recommendations regarding the dosage and schedule of taking the drug.
Interactions with other drugs
Before you start taking Calcitrin, you should tell your doctor about all other drugs you take, including prescription drugs, over-the-counter drugs, and dietary supplements. Some drugs may interact with Calcitrin, which may change its effectiveness or increase the risk of side effects.
Important information
Calcitrin should be used only as directed by a physician. It is not recommended to change the dosage or stop taking the drug without consulting a medical specialist.
If you experience any unusual or unpleasant symptoms while taking Calcitrin, seek medical attention immediately.
Conclusion
Calcitrin is a parathyroid hormone medication used to treat various conditions associated with bone turnover and hormonal imbalances. It may be effective in treating osteoporosis, bone pain, Paget's disease and other conditions. However, before starting to use Kal